EUVIMEDEUVIMED entdecken
Crossref

Prevalence of Human Leukocyte Antigen ( HLA )‐B*58:01 and Allopurinol‐Induced Adverse Reactions in Filipino Patients in Hawai'i: Implications for Genotyping

Rika Terashima iD, Alejandro Jude P Medina, Hans Jesper F Del Mundo, Ryan Sean S Briones, Joseph Arman B Aquino, Ellaine M Quiminiano, Yuh Miin Sin, Rhea A Bautista, Charlie Y Sonido, Seiji Yamada

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Rika Terashima und 9 weiteren Autor:innen. Beteiligte Einrichtung: Primary Care Clinic of Hawaii, Waipahu, Hawaii, USA. Hauptthemen laut MEDLINE: Allopurinol, Drug Eruptions, Gout Suppressants, HLA-B Antigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Allopurinol, a first‐line treatment for gout and hyperuricemia, is associated with severe cutaneous adverse reactions (SCAR) in individuals carrying the HLA‐B*58:01 allele. Genotyping is conditionally recommended in Han Chinese, Korean, and Thai populations with an allele prevalence of 7.4%, and in African Americans at 3.8%. The prevalence in Filipino patients has not been studied. We investigate the prevalence of HLA‐B*58:01 among Filipino patients in Hawai'i and evaluate the incidence of allopurinol‐induced adverse reactions following genotyping.

Methods

We conducted a retrospective chart review of 312 patients who underwent HLA‐B*58:01 genotyping at a primary care clinic in Hawai'i between November 2021 and July 2024. After excluding patients with missing ethnicity data, non‐Filipino ethnicity, or prior allopurinol use, 237 Filipino patients were included in the analysis. The prevalence of the HLA‐B*58:01 allele and the incidence of allopurinol‐induced adverse reactions were calculated.

Results

Among the 237 Filipino patients, 17 (7.2%) were HLA‐B*58:01 positive. A total of 97 patients were started on allopurinol after genotyping and 1 (1.0%) developed mild cutaneous reactions, 0 (0%) developed SCAR, and 2 (2.1%) experienced gastrointestinal symptoms (nausea and diarrhea).

Conclusion

The high prevalence of HLA‐B*58:01 allele among Filipino patients in Hawai'i suggests that genotyping may be considered before initiating allopurinol treatment. Given no instances of SCAR were observed in patients who were administered allopurinol after undergoing HLA‐B*58:01 genotyping, genotyping may play a crucial role in reducing the risk of allopurinol‐induced SCAR in this population. Further studies with larger cohorts are suggested to confirm our findings and assess broader clinical utility of genotyping.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllopurinolDrug EruptionsGout SuppressantsHLA-B AntigensAdultAgedFemaleHumansMaleMiddle AgedAsian PeopleGenotypeHawaiiPhilippinesPrevalenceRetrospective Studies

Stichwörter der Autor:innen

FilipinoHLA‐B*58:01Hawaiiadverse drug reactionsallopurinolgenotypinggout

Substanzen

AllopurinolGout SuppressantsHLA-B AntigensHLA-B*58:01 antigen

Autor:innen und Institutionen

  • Primary Care Clinic of Hawaii, Waipahu, Hawaii, USA.
  • Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.
  • A.T. Still University School of Osteopathic Medicine in Arizona, Mesa, Arizona, USA.
  • Department of Family Medicine and Community Health, University of Hawai'i John A. Burns School of Medicine, Honolulu, Hawaii, USA.

ORCID-Profile: Rika Terashima

Zitieren

APA

Terashima, R., Medina, A. J. P., Del Mundo, H. J. F., Briones, R. S. S., Aquino, J. A. B., Quiminiano, E. M., Sin, Y. M., Bautista, R. A., Sonido, C. Y., & Yamada, S. (2025). Prevalence of Human Leukocyte Antigen ( HLA )‐B*58:01 and Allopurinol‐Induced Adverse Reactions in Filipino Patients in Hawai'i: Implications for Genotyping. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70127

Vancouver

Terashima R, Medina AJP, Del Mundo HJF, Briones RSS, Aquino JAB, Quiminiano EM, et al. Prevalence of Human Leukocyte Antigen ( HLA )‐B*58:01 and Allopurinol‐Induced Adverse Reactions in Filipino Patients in Hawai'i: Implications for Genotyping. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70127

BibTeX
@article{Terashima2025,
  author = {Terashima, Rika and Medina, Alejandro Jude P and Del Mundo, Hans Jesper F and Briones, Ryan Sean S and Aquino, Joseph Arman B and Quiminiano, Ellaine M and Sin, Yuh Miin and Bautista, Rhea A and Sonido, Charlie Y and Yamada, Seiji},
  title = {Prevalence of Human Leukocyte Antigen ( HLA )‐B*58:01 and Allopurinol‐Induced Adverse Reactions in Filipino Patients in Hawai'i: Implications for Genotyping},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70127}
}
Kostenlos starten →